Due to growing evidence of STAG2 being associated with worse overall survival and prognosis, mutations within this gene have been included as a part of the diagnostic criteria for adult AML as suggested by an expert panel on behalf of European LeukemiaNet (ELN) (Döhner et al., 2022). Here, STAG2 is linked to acute myeloid leukemia.